Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I, Open-label, Study to Determine the Absorption, Metabolism, and Excretion of [14C]-E6007 After a Single Oral Administration in Healthy Male Subjects

NCT03444818 is registered in ClinicalTrials.gov with EA Pharma Co., Ltd. as lead sponsor.

NCT NCT03444818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03444818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I, Open-label, Study to Determine the Absorption, Metabolism, and Excretion of [14C]-E6007 After a Single Oral Administration in Healthy Male Subjects
Lead sponsor
EA Pharma Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
April 17, 2018
Completion date
June 26, 2018
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy male participants